SHILPA MEDICARE LTD Fair Value
SHILPAMED · Healthcare · Current price ₹916.8
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹128 | 9% ROE fading to 12% over ~3 yrs, on ₹132 book |
| Relative P/E | ₹487 | EPS × 39.1 peer-median P/E |
| Graham floor | ₹192 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹775 | Street consensus 12-month target price |
Is SHILPA MEDICARE LTD undervalued?
DocStoX estimates the fair value of SHILPA MEDICARE LTD at ₹335 per share, versus the current market price of ₹917. That puts the stock about -63.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹128), Relative P/E (₹487), Graham floor (₹192), Analyst target (₹775). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹128 (bear) to ₹335 (base) to ₹775 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SHILPA MEDICARE LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.